US approves anal cancer vaccine

Dec 23, 2010

US health authorities have approved a vaccine intended to prevent anal cancer and pre-cancerous lesions in young people aged nine to 26 years old.

The (FDA) gave the green light Wednesday to the makers of the Gardasil, which is already used to treat women with cervical, vulvar, and vaginal cancer, and associated lesions caused by the human papillomavirus (HPV) types 6, 11, 16, and 18, officials said.

"Treatment for anal cancer is challenging; the use of Gardasil as a method of prevention is important as it may result in fewer diagnoses and the subsequent surgery, radiation or that individuals need to endure," said Karen Midthun, director of the FDA Center for Biologics Evaluation and Research.

Although anal cancer is rare in the general population, its occurence is increasing especially among gay men, officials noted.

The American Cancer Society estimates about 5,300 people are diagnosed with anal cancer each year in the United States, with more women diagnosed than men.

Explore further: Bangladesh jails three over drug scam that killed hundreds of children (Update)

add to favorites email to friend print save as pdf

Related Stories

FDA considers expanded use of HPV vaccine

Mar 20, 2008

Pharmaceutical manufacturer Merck & Co. Inc. said the U.S. Food and Drug Administration will consider expanding the use of its cervical cancer vaccine.

Some men want girls' vaccine, too

Feb 23, 2007

Some British gay men want to be vaccinated with the drug approved to protect girls from cervical cancer, saying it could help them, too.

New HPV vaccine under study

Nov 19, 2007

A new vaccine against nine of the most harmful strains of human papillomavirus is under study at the Medical College of Georgia.

FDA: Merck's Gardasil stops genital warts in boys

Sep 04, 2009

(AP) -- Merck's blockbuster vaccine Gardasil, which is already used to prevent cervical cancer in women, also stops viruses that cause genital warts in men, the Food and Drug Administration said Friday.

HPV vaccine reduces abnormal pap test results

Mar 10, 2008

In testing GARDASIL reduced abnormal Pap test results by 43 percent compared to women not given the vaccine, according new research. The findings show the approved anti-HPV agent appears to prevent the development of cell ...

Recommended for you

Supermaterial gives rejected drugs a new chance

18 hours ago

More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new ...

Risk of antibiotic overuse in aged care settings

Jul 21, 2014

Antibiotics are being overused in residential aged care facilities (RACFs), and more integrated efforts to improve antibiotic prescribing practices need to be introduced, researchers say. 

Ruconest approved for rare genetic disease

Jul 17, 2014

(HealthDay)—Ruconest has been approved by the U.S. Food and Drug Administration to treat hereditary angioedema, a genetic disease that leads to sudden and potentially fatal swelling of the hands, feet, limbs, face, intestinal ...

NIH system to monitor emerging drug trends

Jul 17, 2014

An innovative National Drug Early Warning System (NDEWS) is being developed to monitor emerging trends that will help health experts respond quickly to potential outbreaks of illicit drugs such as heroin and to identify increased ...

User comments : 3

Adjust slider to filter visible comments by rank

Display comments: newest first

bhiestand
not rated yet Dec 23, 2010
Ugh, I hate everyone calling Gardasil a "cancer vaccine". It's an HPV vaccine. It works on these strains of HPV, whether anal or genital, right? So it's not a new drug, nor a cancer vaccine, nor approval of a new drug... it's just acknowledging that this drug also helps prevent anal infections of HPV 6, 11, 16, and 18, right?

The big news would be if they'd open this vaccine up to people older than 26.
banjo
not rated yet Dec 24, 2010
HPV16 is also implicated in Head and Neck cancers which have a 6:1 male preponderance.
USA and Swedish statistics show a new wave of these cancers in younger people and non-smokers.
H&N cancers are notoriosly difficult to detect as the primary stage, can be difficult to treat, and a nasty way to die.

My husband was diagnosed aged 47yrs and under went R) cevical node dissection, radiation 33 shots, and concurrent weekly chemo with cisplatin.

Re age of vaccination- ideally it is given before people are sexually active. Within the adult population, 50% have evidence of HPV exposure.
Of course I have had my teen son vaccinated, and my daughter has been vaccinated with free school program.

I hope in the future babies are immunised as infants, as for HepB. And for free (vs $500 Australian)
Wesleyfeng
not rated yet Dec 30, 2010
the United States Food and drug administration approved the usage of Gardasil, a human papillomavirus (HPV) vaccine, in the reduction of cervical cancer. Implementation fomented a yeast of dispute, as some states made vaccinations mandatory for girls as young as nine. Here is the proof: FDA approves use of Gardasil against anal cancer. Throw in a number of peculiar deaths some experts directly linked to the use of Gardasil and the FDA's decision was placed under scrutiny. Now the vaccine has formally joined up with the battle against anal cancer, reports CNN.